How COVID-19 Strengthened the Supply Chain and Key Takeaways for the Future
PM360, Heather Zenk, PharmD
March 11, 2021 marked one year since the coronavirus was declared a global pandemic by the World Health Organization (WHO). Over that past year, the pandemic has reinforced the exceptional resilience of the pharmaceutical supply chain in the face of unprecedented challenges. Given their position at the center of the supply chain, pharmaceutical distributors have identified lessons and efficiencies that have proven especially valuable as COVID-19 vaccine rollouts continue across the United States.
Distributors, manufacturers, hospitals, and other key players have successfully maintained critical business functions throughout the pandemic.
Read the full article from Heather Zenk, PharmD on PM360 here.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.